Gene Therapy: Spark Charts A Course From Science To Payer And Patient Satisfaction

Furey_John_1200.jpg
John Furey, chief operating officer of Spark Therapeutics • Source: Spark Therapeutics

More from C-Suite Speaks

More from Leadership